Christopher Coons (D-DE)
Biomanufacturing Excellence Act of 2025
A Democratic bill with 3 Republican cosponsors · See all 5 cosponsors
Last activity — Read twice and referred to the Committee on Commerce, Science, and Transportation.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The Biomanufacturing Excellence Act of 2025 aims to establish a National Biopharmaceutical Manufacturing Center of Excellence. This center is intended to advance the science of biopharmaceutical manufacturing to protect national, health, and economic security. The bill directs the Director to award grants or agreements to eligible entities, such as higher education institutions or public-private partnerships, to operate the center. Objectives include improving manufacturing technologies, supporting workforce training, and developing necessary infrastructure. The center will also focus on reducing supply chain bottlenecks and strengthening self-sufficiency. This legislation authorizes $120,000,000 for fiscal year 2026 to carry out these efforts.
Yes· 3 of 12
- Scored +7
Does this put more money into scientific research?
The bill authorizes $120,000,000 to fund collaborative research and development in biomanufacturing.
- Scored +5
Is this likely to create jobs?
The bill promotes workforce training and development to bolster talent in the biotechnology sector.
- Scored +5
Would business owners be better off under this?
The bill provides resources to help manufacturers scale their products and achieve a return on investment.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved Health and Treatments: The bill notes that biopharmaceutical manufacturing can enable better and less invasive treatments that extend and improve lives (Section 2(a)(3)).
-
Workforce Training and Development: The center is tasked with advancing workforce training and working with educational and community partners to bolster biotechnology talent (Section 3(a)(2)(C)). Funding can specifically be used for these workforce training programs (Section 3(a)(3)(C)).
-
Increased Supply Chain Security: By investing in biomanufacturing, the government aims to reduce dependency on foreign supply chains (Section 2(a)(4)). The center's objectives include reducing supply bottlenecks and strengthening supply chain self-sufficiency (Section 3(a)(2)(A)(i)).
-
Economic and National Security: The center aims to advance science related to products of particular importance to the national security, health security, or economic security of the United States (Section 3(a)(2)(A)).
Potential Negative Impacts for People
- No specific negative impacts or burdens are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Economy And Finance
- Is this likely to create jobs? — The bill promotes workforce training and development to bolster talent in the biotechnology sector. Is this likely to grow the economy? — The bill aims to advance biopharmaceutical manufacturing to strengthen national economic security. Does this make it easier to run a small business? — The bill encourages collaboration with small pharmaceutical manufacturers to scale their products.
- Demographic And Interest Groups
- Would business owners be better off under this? — The bill provides resources to help manufacturers scale their products and achieve a return on investment. Would students be better off under this? — The bill facilitates workforce training through partnerships with educational institutions.
- Education And Technology
- Does this put more money into scientific research? — The bill authorizes $120,000,000 to fund collaborative research and development in biomanufacturing. Does this make college cost less? — The bill involves institutions of higher education in the establishment of the Center of Excellence.
- Healthcare
- Does this make health care easier to get in general? — The bill aims to improve the production of medicines through advanced biopharmaceutical manufacturing.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill requires the Director to make progress reports available to the public in an easily accessible electronic format.
- Environment Energy And Infrastructure
- Does this invest in rural communities? — The bill includes the development of infrastructure for biopharmaceutical manufacturing.
- National Security And Foreign Policy
- Does this better protect the country from computer attacks? — The bill mentions protecting national and health security through manufacturing self-sufficiency.
- Social Issues And Justice
- Is this likely to lift people out of poverty? — The bill's focus on workforce training may provide upward mobility for workers in the biotechnology sector.
- 5/19/2026
- 1 Cosponsor added.
- 5/14/2026
- 1 Cosponsor added.
- 3/11/2026
- 2 Cosponsors added.
- 11/18/2025
- Read twice and referred to the Committee on Commerce, Science, and Transportation.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Lisa Blunt RochesterDemocrat · Delaware
Ted BuddRepublican · North Carolina
Alex PadillaDemocrat · California
Thomas TillisRepublican · North Carolina
Todd YoungRepublican · Indiana